Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites
Ann Dermatol Venereol. 2023 Nov 10:S0151-9638(23)00084-4. doi: 10.1016/j.annder.2023.09.002. Online ahead of print.NO ABSTRACTPMID:37953102 | DOI:10.1016/j.annder.2023.09.002 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - November 12, 2023 Category: Dermatology Authors: A Badaoui I Moulonguet Source Type: research

The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma
Ann Dermatol Venereol. 2023 Nov 9:S0151-9638(23)00082-0. doi: 10.1016/j.annder.2023.05.006. Online ahead of print.NO ABSTRACTPMID:37951762 | DOI:10.1016/j.annder.2023.05.006 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - November 11, 2023 Category: Dermatology Authors: B Demarez C Gaudy F Amatore F Correard C Tab èle M-A Richard Source Type: research

The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma
Ann Dermatol Venereol. 2023 Nov 9:S0151-9638(23)00082-0. doi: 10.1016/j.annder.2023.05.006. Online ahead of print.NO ABSTRACTPMID:37951762 | DOI:10.1016/j.annder.2023.05.006 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - November 11, 2023 Category: Dermatology Authors: B Demarez C Gaudy F Amatore F Correard C Tab èle M-A Richard Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer
Ann Dermatol Venereol. 2023 Oct 28:S0151-9638(23)00083-2. doi: 10.1016/j.annder.2023.09.001. Online ahead of print.NO ABSTRACTPMID:37903707 | DOI:10.1016/j.annder.2023.09.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 30, 2023 Category: Dermatology Authors: P-F Guglielmini C Massone C Grasso A Francese M Vincenti S Chiodi M Rossi A Maconi Source Type: research

Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners
Ann Dermatol Venereol. 2023 Oct 9:S0151-9638(23)00070-4. doi: 10.1016/j.annder.2023.07.001. Online ahead of print.NO ABSTRACTPMID:37821251 | DOI:10.1016/j.annder.2023.07.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: M Benzaquen L Christ N Sutter B C Özdemir Source Type: research

Evaluation of parents' knowledge following a sun-protection campaign in schools in La Reunion
Ann Dermatol Venereol. 2023 Oct 9:S0151-9638(23)00058-3. doi: 10.1016/j.annder.2023.03.012. Online ahead of print.NO ABSTRACTPMID:37821252 | DOI:10.1016/j.annder.2023.03.012 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Breton L Bruneau J Dumez J Miquel F Villeroy M Beylot-Barry N Sultan-Bichat A Bertolotti Source Type: research

A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
CONCLUSION: This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.PMID:37821253 | DOI:10.1016/j.annder.2023.06.009 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - October 11, 2023 Category: Dermatology Authors: N Sigg J Fouquet D Morin D Farges S Vrignaud L Martin Source Type: research